Filing Flows › AtriCure (ATRC) › Q1 2025
AtriCure (ATRC) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 30, 2025
AtriCure (ATRC) reported revenue of $124M for the first quarter 2025 (Q1 2025), +14% from a year earlier and -0.5% from the quarter before. Operating margin was -4.8%, net loss $6.7M (5.5% of revenue).
AtriCure, Q1 2025: revenue $124M (+14% year over year), operating margin -4.8%, net loss $6.7M, operating cash flow −$11.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $124M | -0.5% | +14% |
| Operating profit | −$6.0M | — | — |
| Net earnings | −$6.7M | — | — |
| Operating cash flow | −$11.0M | — | — |
What changed
Revenue was $123.6M in Q1 2025, up 14% year over year and down 1% from the previous quarter.
Gross margin was 74.9%, up 0.3 points from a year earlier. Operating costs exceeded revenue by $6.0M, an operating margin of -4.8%. Operating expenses grew 7% against revenue growth of 14%. The fastest-growing cost line was Research & development (+14%). The quarter ended with a net loss of $6.7M, narrower than the previous quarter's $15.6M loss.
Operating cash flow was −$11.0M. Non-cash charges added back $5.1M of depreciation and amortization and $9.6M of share-based compensation. Working capital and other items used $19.0M. Capital expenditures of $2.2M exceeded it, leaving free cash flow of −$13.2M.
Questions
What was AtriCure's revenue in the first quarter 2025?
AtriCure (ATRC) reported revenue of $124M for the first quarter 2025 (Q1 2025), +14% from a year earlier and -0.5% from the quarter before.
Was AtriCure profitable in the first quarter 2025?
Operating loss was $6.0M (-4.8% of revenue) and net loss $6.7M.
Source: AtriCure 10-Q on SEC EDGAR.